1. End-Stage Renal Disease and Critical Limb Ischemia: A Deadly Combination?
- Author
-
E. Arvela, M. Korhonen, Fausto Biancari, Maarit Venermo, Anders Albäck, Mauri Lepäntalo, Maria Söderström, and Karoliina Halmesmäki
- Subjects
Male ,medicine.medical_specialty ,Percutaneous ,medicine.medical_treatment ,Urology ,Revascularization ,Amputation, Surgical ,End stage renal disease ,Ischemia ,Odds Ratio ,medicine ,Humans ,Propensity Score ,Survival analysis ,Dialysis ,Aged ,Retrospective Studies ,Aged, 80 and over ,Peripheral Vascular Diseases ,Leg ,business.industry ,Angioplasty ,Odds ratio ,Critical limb ischemia ,Limb Salvage ,Survival Analysis ,Surgery ,Logistic Models ,Treatment Outcome ,Bypass surgery ,Kidney Failure, Chronic ,Female ,Vascular Grafting ,medicine.symptom ,business - Abstract
Objectives: This study was planned to evaluate the prognostic impact of end-stage renal disease (ESRD) in patients with critical leg ischemia (CLI) undergoing infrainguinal revascularization. Materials and Methods: 1425 patients who underwent infrainguinal revascularization for CLI were the subjects of the present analysis. Ninety-five patients had ESRD (eGFR < 15 ml/min/m2), and of them 66 (70%) underwent percutaneous transluminal angioplasty and 29 (30%) underwent bypass surgery. Results: ESRD patients had significantly lower overall survival (at 3-year, 27.1% vs. 59.7%, p < 0.0001), leg salvage (at 3-year, 57.7% vs. 83.0%, pConclusions: Lower limb revascularization in patients with CLI and end-stage renal failure is associated with favourable leg salvage. However, these patients have a very poor survival and this may jeopardize any attempt of revascularization. Further studies are needed to identify ESRD patients with acceptable life expectancy and who may benefit from lower limb revascularization.
- Published
- 2012
- Full Text
- View/download PDF